Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-18

FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved a supplemental application for Tamsulosin hydrochloride from XLCare Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin hydrochloride (tamsulosin hydrochloride)

Snippet

SUPPL AP for TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN HYDROCHLORIDE)